THERAVANCE BIOPHARMA
LIVE

Serial Number

79260681

Owner

Theravance Biopharma Ireland Limited

Attorney

Beth H. Alter

Filing Date

Feb 8, 2019

Add to watchlist:

No watchlists yet
View on USPTO

THERAVANCE BIOPHARMA Trademark

Serial Number: 79260681 • Registration: 6061018

THERAVANCE BIOPHARMA is a trademark filed by Theravance Biopharma Ireland Limited on February 8, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Theravance Biopharma Ireland Limited (8 trademarks)

10 Earlsfort Terrace,

Entity Type: 99

Trademark Details

Filing Date

February 8, 2019

Registration Date

May 26, 2020

Published for Opposition

March 10, 2020

Goods & Services

Pharmaceuticals, medical and veterinary preparations for the treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, neurological, ocular, dermatological, genito-urinary, integumentary, immune and central nervous systems; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; diagnostic preparations and materials for medical, pharmaceutical and veterinary purposes; dietary supplements and dietetic preparations; disinfectants and antiseptics; medical dressings, coverings; pharmaceuticals and natural remedies for the treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, neurological, ocular, dermatological, genito-urinary, integumentary, immune and central nervous systems; pharmaceutical products for treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders; pharmaceutical preparations and substances for the treatment of bacterial and viral infections, namely anti-infectives

Scientific and technological services and research and design relating thereto, namely, scientific research, analysis, design and testing in the field of pharmaceuticals and medicine; medical and pharmacological research services; natural science services, namely, scientific research, analysis, design and testing in the field of natural medicine and natural remedies; testing, authentication and quality control in the field of pharmaceuticals and medicine; scientific investigation for medical purposes; bacteriological, chemical and biological investigation in the field of pharmaceuticals and medicine

Filing History

CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 23, 2026 APRE
TEAS SECTION 71 & 15 RECEIVED
May 18, 2026 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 26, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 23, 2023 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 17, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 24, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 24, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 26, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
May 26, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Mar 7, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 19, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 19, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2020 TROA
REFUSAL PROCESSED BY IB
Aug 2, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jul 13, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 26, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jun 25, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 22, 2019 MAFR
ASSIGNED TO EXAMINER
Jun 18, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 18, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 13, 2019 REPR